Obstetrical shock

49,718 views 50 slides Jul 31, 2019
Slide 1
Slide 1 of 50
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50

About This Presentation

This topic contains definition, meaning, classification, pathophysiology, clinical menifestations, metabolic and general changes, management of obstetrical shock


Slide Content

“Shock is defined as a state of
circulatory inadequacy with poor tissue
perfusion resulting in generalized
cellular hypoxia.”

Circulatory inadequacy is due to a
disparity between the circulating
blood volume and the capacity of
the circulatory bed.
The net effect of this diparity is
inadequate exchange of oxygen
and carbon dioxyde between the
intra and extravsacular
compartments.

The stagnation of carbon dioxyde
and other metabolites in the tissue
leads to metabolic acidosis and
cellular death.
The series of changes observed in
shock and their clinical
manifestations, are therefore,
dependent on two sets of changes:
a)Circulatory inadequacy at the
'filtration level'
b)Cellular damage and ultimately
death.

CARDIO
GENIC
SHOCK
EXTRA
CARDIC
SHOCK
SEPTIC
SHOCK
HYPO
VOLEMIC
SHOCK

Circulating blood volume is inadeuate
resulting from acute depletion.
It may be-

Hemorrhagic shock
Associated with postpartum or
postabortal hemorrhage, ectopic
pregnancy, placenta previa, abruptio
placenta, rupture of the uterus and
obstetric surgery.
Shock associated with disseminate
intravsacular coagulation, intrauterine
dead fetus syndrome and amniotic fluid
embolism.

Non Hemorrhagic shock
Fluid Shock:-
Associated with excessing vomiting,
diarrhea, diuresis or too rapid removal of
amniotic fluid.
Supine Hypotensive Syndrome:-
Due to compression of inferior vena cava
by the pregnant uterus.

Hypotension is due to sepsis resulting
in derangements in cellular and organ
system dysfunction.
Hypotension persists in spite of
adequate fluid resuscitation.
Associated typically with septic
abortion, chorioamnionitis and rarely
postpartum endometriosis.

Characterised by...
Decreased systolic pressure ( <80 mm
Hg)
Decreased Cardiac Index (<1.8 L /min/m2)
Increased left ventricular filling pressure
(> 18 mm Hg)

Massive pulmonary embolism, amniotic
fluid embolism, anaphylaxis, drug
overdose, neurogenic.

Chemical injury:-
Associated with aspiration of
gastrointestinal contents during general
anesthesia (Mendelson's syndrome)
Drug induced:-
Associated with spinal anesthesia.

Pathophysiological changes in obstetric
shock are predominantly associated with..
a)General changes due to hypovolemia
b)Specific changes due to liberation of
endotoxin

Hypotension stimulates release of
neuroendocrine mediators like
adrenocorticotropic hormone (ACTH),
Growth hormone (GH), β endorphin,
cortisol and glucagon.
There is also sympathoadrenal
response.
Presence of endotoxin
(lipopolysaccharide), in septic shock
activates the luecocytes through
complement system.

There is release of inflammatory
mediators such as protease,
superoxide (o
2
-
), hydroxy (OH
-
)
radicals, cytokines, prostaglandins
and many cytotoxic enzymes.
These interfere with the function of
a number of enzyme systems and
increase capillary permiability.

Cytiokines such as interleukines (ILS)
and tumor nacrosis factor ( INF)
interact by autocrine and paracrine
mechanism to cause cellular or organ
dysfunction.
In presense of hypoxia, sepsis and
acidosis, lysosomal emzymes which
are cytotoxic, are released.
They can cause myocardial depression
and coronary vasoconstriction.

Prostacycline is a vasodilator and
inhibits platelet aggregation.
Thromboxane A
2
causes pulmonary
vasoconstriction and platelet
aggregation.
Leukotrines cause vasoconstriction,
platelet activation and increased
vascular parmiability.
Endothelium derived relaxing factor
( EDRF) which is identified as an nitric
oxide (NO) is found to produce
sustained vasodilation and
hypotension.

Thrombosis is increased due to inhibition
of antithrombin III.
Thrombocytopenia is common.

Hepatic glycogenolysis due to
increased level of glucagon,
catecholamine and cortisol leads to
hyperglycemia.
There is diminished peripheral
utilization of glucose due to incearsed
level of insulin antagonist like cortisol
and growth hormone.

Inadquate oxygen supply to issue
initiates anaerobic metabolism.
Consequently there is metbolic
acidosis, production of lactic acid and
H
+
irons.
Sodium pump fails to operate.
Finally the lysosomal enzymes are
released.
These lead to cell death.

There are four phases of changes.
The first two phases are reversible, the
third one probably correctable and
fourth is irreversible.

Sympathetic impuses and the level of
cicrculating catacholamines increase in
response to hypovolemia, cardiogenic or
neurogenic stimulus.
Stretch receptors monitoring blood pressure in
the carotid sinus and aortic arch supply
information to the vasomotor centre via the
ninght and tenth cranial nerves.
The vasomotor centre responds by sending
efferent impulses through the sympathetic
nervous sytem.

As a result of excessive sympathetic
stimulus, there is constriction of the pre
and post capillary sphincters, resulting in
inadequate venous return leading to
diminished cardiac output, clinical
manifestations of which are hypotension
and tachycardia.

The mechanisms attempt to correct
hypovolemia, improve cardiac output
and the perfusion of vital organs.
At this stage, transfusion and control
of haemorrhage are usually effective in
restoring the normal circultory balance
and tissue perfussion.
On the otherhand, if bleeding continues
or treatment is delayed, the changes at
microcirculatory unit will continue to
persist and will pass into the third and
fourth phases of shock.

Prolonged anoxia of the tissues will lead to
excessive production of lactic acid (acidosis).
Lactic acid and anoxia cause relaxation of the
precapillary sphincters.
In addition, thromboxane A
2
and leukotrines
(endogenous mediators) cause damage to the
endothelial cells of the capillaries of the
microcirculatory beds.
These lead to formation of thrombus within the
capillaries (diffuse intravascular coagulation
and increaded capillary permiability.

Consequent to persistant constriction of
the postcapillary sphincter, blood remains
stagnant within the capillary bed.
Fuid from the capillaries leaks in to the
tissue spaces due to increased
permiability.
All fluids administered intravenously will
go into the tissue spaces and circulatory
blood volume cannot be restored.

Clinically, this is the stage of
irreversible shock.
There is severe loss of systemic
vascular resistence, severe myocardial
depression, (decreased cardiac
output), unresponsive hypotension and
ultimately multiple organ system
failure.

Endotoxic shock usually follows infection
with Gram-negative organism (75-80 %).
The most common organism involved is
Escherichia coli (50 %).
Other organism occasionally responsible
for endotoxic shock are, Pseudomonas
aeruginosa, klebsiella, proteus,
bacteroides and aerobacter aerogenes.

Gram positive organisms, anaerobes,
clostridium group are less common
(20%).
Bacterial endotoxin causes selective
vasospasm at the postcapillary end.
Blood is pooled in the capillary bed.
There is inhibition of myocardial
function and cellular damage through
complex biochemical changes.

The patient in early septic shock feels
warm due to vasoconstriction.
This is called Warm shock.
In the late phase, the patient feels cold
due vasoconstriction.
This is called cold shock or late shock.
Patient's skin becomes cold, clammy
and ashen gray.

VARIOUS BIOCHEMICAL AND PATHOLOGICAL
CHANGES IN ENDOTOXIC SHOCK
Diffuse intravsacular coagulation
Increased capillary permiability
Metabolic acidosis
Release of superoxide and hydroxyl
radicals
Failure of sodium pump operation
Water and electrolyte imbalance
Excessive and uncontrolled systemic
inflammatory response (SIR) - leads to
organ changes

Organ changes depends on the degree
of hypoperfusion and extent of the
underlying pathology:
Kidney: Patchy and massive chortical
necrosis leading to oliguria, anuria and
azotemia. Persistant hypotension
leads to acute tubular necrosis and
ultimately renal failure.
Liver: Hepatocellular necrosis and
degeneration ultimately leading to
hepatic failure.

GI Tract: Hypoxic mucosal injury increases
systemic sepsis by translocation of
intraluminal microbes. Congestion,
hemorrhage and ulceration are responsible
for hematemesis.
Lungs: Congestion or atelectasis leads to
tachypnea, progressive hypoxemia and
reduced pulmonary compliance.
ARDS results from increased capillary
permiability and thickening of the alveolar
capillary membranes. Arterial PaO
2
is low.
Mechanical ventilation is needed.

Heart: Cardiac output decreases
depending on the degree of hypotension,
hypoperfusion and vasoconstriction.
Myocardial
Ischemia
Cardiac
Dysfunction
Dysrrhythmia
Cardiac
Failure
Increased
LVEDP
Pulmonary
Edema
Tissue
Hypoxia
LVEDP: Left Ventricular End
Diastolic Pressure

Ultimately multiple organ failure
develops.
Endotoxins have got special affinity for
kidneys and lungs for reasons which
are not very clear.

Clinical features of shock depend on
the basic etlogical factors and
consequently the sequence of
pathological changes occuring within
the microvascular unit.
In early, the features of hypovolemic
and septic shock are different.
In the irreversal phase, the clinical
features are the same as the final
pathology is multiple organ failure.
It carries mortality of 30%-100%.

HEMORRHAGIC SHOCK
Early Phase (Compensoatory Phase):
In the realy phase there is mild vaso-
constriction and with the compensatory
mechanism operating, the patient has
relatively normal blood pressure, tachy-
cardia and diaphoresis.
Extremities remain warm.
Patient appears restless and anxious.
This phase can be easily managed by
volume replacement.

Intermediate Phase (Reversible Phase):
If the early phase remains untreated, the
patient passes in to the state of hypotension.
Pateint progressively becomes pale,
tachycardia persists and due to intense
vasoconstriction, the periphery becomes cold
and there may be sweating.
Due to diversion of blood to vital organs, the
patient remains conscious and the urine
output is within normal limits.
Still with the adequate management, the
shock state can be reversed.

Late Phase (Irreversible Phase):
Hypotension continues and can not be
reversed by fluid replacement because of
stagnation of blood at the micro vascular
level.
Extremities becomes cold and clammy
because of vasoconstriction due to
sympathetic stimulation.
For the same reason, color of the skin
becomes ashen gray.

Metabolic acidosis, coagulaopathy and
thrombocytopenia are associated.
Practically imperceptible low volume
pulse, oliguria, mental confusion
( multiple organ failure) are the
combined results of circulatory failure
and anaerobic metabolim.
Treatment of any kind is practically
useless in this phase and mortality
varies between 3% and 100%.

NEUROGENIC SHOCK
The basic phathological factors in both
hemorrhagic and neurogenic shock are
more or less the same except for the fact
that hemorrhagic shock is hypovolemic
and neurogenic shock, initially is
normovolemic, though this becomes
hypovolemic in the later phase due to
pooling and stagnation of blood in the
micro vascular capillaries.

The compensatory phase in neurogenic
shock, however, very transient.
In the revesible phase, unlike
hypovolemic shock, pallor is absent,
on the contray, the face may be
flushed.
Moreover neurogenic shock does not
show expected response to volume
replacement.
Temperature remains normal or
subnormal.

ENDOTOXIC SHOCK
In the initial phase of endotoxic shock
because of precapillary dilatation and
diversion of blood through metarteriolar
shunt, the patient remains alert, there is
marked flushing of the face and the skin
feels warm.
There are temperature change >38℃ or
< 36℃, bounding pulse, heart rate >100
beatsper min, respiratoryrate > 20/min,
WBC > 12000/mL
3

When, however, the state of shock
persists, there is intense constriction
of sphincters at either end of the
capillary bed.
The patient becomes pale and there is
profuse sweating.
Exremities are cold and clammy.
Urine output is markedly reduced.
If the shock condition does not
improve, the patient passes clinacally
to the stage of 'irreversible shock'.

She remains cold and clammy with
ashen gray cynotic appearance.
Severe sepsis is associated with
hypotension (<90 mm Hg systolic)->
organ hypoperfusion and dysfuction->
lactic acidosis-> oliguria, renal failure,
ARDS, cardiac failure-> multiple organ
dysfunction syndrome.

HEMORRHAGIC SHOCK:
Basic management of hemorrhagic shock
is to stop the bleeding and replace the
volume which has been lost.
Restoring circulatory volume
Maintenance of cardiac efficiency
Administration of oxygen to avoid
metabolic acidosis
Pharmacological agents- corticosteroids
Control of hemorrhage

ENDOTOXIC SHOCK
INVESTIGATIONS:
CBC
Hematocrit
Coagulation Profile
Liver and Renal function test
Chest radiography
 USG, CT, MRI
ECG monitoring

PRINCIPLE OF MANAGEMENT:
To correct the hemodynamic unstability
due to sepsis
Appropriate supportive care
To remove the source of sepsis
Two wide bore cannulas sited.
Foly's catheter.
Oxygenation with face mask is to be
given.
Mechanical ventilation may be needed in
severe cases.

Antibiotics
IV fluids and electroytes
Correction of acidosis
Maintenance of blood pressure
Vasodilator therapy
Diuretic therapy
Corticosteroids
Treatment of diffuse intravsacular
coagulopathy
Treatment of myocarditis
Elimination of source of infection
Intensive insulin therapy